CRC
Clinical trials for CRC explained in plain language.
Never miss a new study
Get alerted when new CRC trials appear
Sign up with your email to follow new studies for CRC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill plus chemo shows promise for Hard-to-Treat colon cancer
Disease control OngoingThis phase 2 trial tests whether adding an experimental drug called onvansertib to standard chemotherapy and bevacizumab can shrink tumors better than chemo alone in people with advanced colorectal cancer that has a KRAS or NRAS mutation. About 110 participants who have not had p…
Matched conditions: CRC
Phase: PHASE2 • Sponsor: Cardiff Oncology • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Cancer combo trial pulled before it even started
Disease control TerminatedThis was a phase 2 study planned to test a new drug called NGM707 combined with the immunotherapy pembrolizumab in people with advanced or metastatic solid tumors, specifically colorectal cancer. The goal was to see if the combination could shrink tumors and to check for side eff…
Matched conditions: CRC
Phase: PHASE2 • Sponsor: NGM Biopharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC